Status:
WITHDRAWN
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
Lead Sponsor:
University of Minnesota
Conditions:
Hyperglycemia in Pregnant Diabetic Patients
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
Our objective is to assess whether pre-treatment with a fixed dose of insulin, based on weight, given to pregnant patients with gestational or preexisting diabetes receiving betamethasone can provide ...
Eligibility Criteria
Inclusion
- Pregnant women with gestational or pre-existing diabetes admitted to the University of Minnesota
- Must be 18 years or older
- Must speak English, Spanish, or Somali
- Patients must receive steroids for fetal lung maturity as part of their hospital course
Exclusion
- Pregnant women with Type 1 Diabetes, or Type 2 diabetes with evidence of end-organ disease
- Pregnant women who need to be emergently delivered due to maternal or fetal complications of pregnancy
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01875107
Start Date
August 1 2013
End Date
August 1 2014
Last Update
September 12 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota Medical Center
Minneapolis, Minnesota, United States, 55454